Oncogene
Displaying 1 - 7 of 7
Arriaga, J. M., Ronaldson-Bouchard, K., Picech, F., Nunes de Almeida, F., Afari, S., Chhouri, H., Vunjak-Novakovic, G., & Abate-Shen, C. (2024). In vivo genome-wide CRISPR screening identifies CITED2 as a driver of prostate cancer bone metastasis. Oncogene, 43(17), 1303–1315. https://doi.org/10.1038/s41388-024-02995-5
Publication Date
Columbia Affiliation
Vagelos College of Physicians and Surgeons; Department of Molecular Pharmacology and Therapeutics; Department of Medicine; College of Dental Medicine; Department of Pathology and Cell Biology; Division of Hematology/Oncology; Department of Systems Biology; Herbert Irving Comprehensive Cancer Center; Department of Urology
Sepich-Poore, G. D., McDonald, D., Kopylova, E., Guccione, C., Zhu, Q., Austin, G., Carpenter, C., Fraraccio, S., Wandro, S., Kosciolek, T., Janssen, S., Metcalf, J. L., Song, S. J., Kanbar, J., Miller-Montgomery, S., Heaton, R., Mckay, R., Patel, S. P., Swafford, A. D., … Knight, R. (2024). Robustness of cancer microbiome signals over a broad range of methodological variation. Oncogene, 43(15), 1127–1148. https://doi.org/10.1038/s41388-024-02974-w
Publication Date
Columbia Affiliation
Minikes, A. M., Song, Y., Feng, Y., Yoon, C., Yoon, S. S., & Jiang, X. (2023). E-cadherin is a biomarker for ferroptosis sensitivity in diffuse gastric cancer. Oncogene, 42(11), 848–857. https://doi.org/10.1038/s41388-023-02599-5
Publication Date
Columbia Affiliation
Burke, A., Borot, F., Du, X., Churchill, M., Ding, J., Grass, A. M., DeSouza, P., Ali, A. M., & Mukherjee, S. (2022). A novel therapeutic bispecific format based on synthetic orthogonal heterodimers enables T cell activity against Acute myeloid leukemia. Oncogene, 42(1), 26–34. https://doi.org/10.1038/s41388-022-02532-2
Publication Date
Columbia Affiliation
He, R., Xhabija, B., Gopi, L. K., Kurup, J. T., Xu, Z., Liu, Z., & Kidder, B. L. (2022). H3K4 demethylase KDM5B regulates cancer cell identity and epigenetic plasticity. Oncogene, 41(21), 2958–2972. https://doi.org/10.1038/s41388-022-02311-z
Publication Date
Columbia Affiliation
Xia, Z., Kon, N., Gu, A. P., Tavana, O., & Gu, W. (2022). Deciphering the acetylation code of p53 in transcription regulation and tumor suppression. Oncogene, 41(22), 3039–3050. https://doi.org/10.1038/s41388-022-02331-9
Publication Date
Columbia Affiliation
View
Yan, H., Yu, C.-C., Fine, S. A., Youssof, A. L., Yang, Y.-R., Yan, J., Karg, D. C., Cheung, E. C., Friedman, R. A., Ying, H., Chen, E. I., Luo, J., Miao, Y., Qiu, W., & Su, G. H. (2021). Loss of the wild-type KRAS allele promotes pancreatic cancer progression through functional activation of YAP1. Oncogene, 40(50), 6759–6771. https://doi.org/10.1038/s41388-021-02040-9
Publication Date
Columbia Affiliation
View